Mucosal delivery of vaccine antigens and its advantages in pediatrics

被引:96
作者
De Magistnis, MT [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
关键词
vaccines; mucosal immune system; adjuvants; delivery systems; mucosal vaccines; pediatric vaccines; mechanism of action of adjuvants;
D O I
10.1016/j.addr.2006.01.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery of vaccines through the mucosal route is very practical, non-invasive and efficacious for the induction of mucosal and systemic immune responses. Appropriately formulated mucosal vaccines can stimulate all arms of the immune system and could be exploited for protection against pathogens that infect the host through the mucosal surfaces as well as those acquired through other routes. There are few available mucosal vaccines so far and these are mainly based on whole microorganisms. The development of new generation mucosal vaccines based on purified protective antigens has been hampered for a long time by the low immunogenicity of soluble antigens and by the lack of safe and efficacious mucosal adjuvants. However, we have now several promising candidate adjuvants and delivery systems for mucosal immunization. In this review I will illustrate the advantages of mucosal vaccination and I will discuss what we still need to develop safe and efficacious mucosal vaccines that would be beneficial especially for young children. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 67
页数:16
相关论文
共 149 条
[1]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[2]  
Agren LC, 1997, J IMMUNOL, V158, P3936
[3]   In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin [J].
Anjuère, F ;
Luci, C ;
Lebens, M ;
Rousseau, D ;
Hervouet, C ;
Milon, G ;
Holmgren, J ;
Ardavin, C ;
Czerkinsky, C .
JOURNAL OF IMMUNOLOGY, 2004, 173 (08) :5103-5111
[4]   ACTION OF SAPONIN ON BIOLOGICAL CELL MEMBRANES [J].
BANGHAM, AD ;
GLAUERT, AM ;
HORNE, RW ;
DINGLE, JT ;
LUCY, JA .
NATURE, 1962, 196 (4858) :952-&
[5]   ISCOMs and other saponin based adjuvants [J].
Barr, IG ;
Sjölander, A ;
Cox, JC .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 32 (03) :247-271
[6]   Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system [J].
Baudner, BC ;
Morandi, M ;
Giuliani, MM ;
Verhoef, JC ;
Junginger, HE ;
Costantino, P ;
Rappuoli, R ;
Del Giudice, G .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :828-832
[7]   The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines [J].
Baudner, BC ;
Giuliani, MM ;
Verhoef, JC ;
Rappuoli, R ;
Junginger, HE ;
Del Giudice, G .
VACCINE, 2003, 21 (25-26) :3837-3844
[8]  
Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643
[9]  
Boyaka PN, 1999, J IMMUNOL, V162, P122
[10]   Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity [J].
Boyaka, PN ;
Marinaro, M ;
Jackson, RJ ;
van Ginkel, FW ;
Cormet-Boyaka, E ;
Kirk, KL ;
Kensil, CR ;
McGhee, JR .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2283-2290